2013 Biotech & Standards Conference Participant: Anthony J. Sinskey

Anthony J. Sinskey
Faculty Director, MIT Center for Biomedical Innovation; Professor, Microbiology and Engineering Systems; Professor, Health Sciences and Technology, Harvard-MIT Division of Health Sciences & Technology, MIT

Anthony J. Sinskey, ScD is Professor of Microbiology and Engineering Systems at the Massachusetts Institute of Technology, and Professor of Health Sciences and Technology at the Harvard-MIT Division of Health Sciences & Technology, MIT. Professor Sinskey also holds positions as Co-Director of the Malaysia-MIT Biotechnology Partnership Program and as Faculty Director of the MIT Center for Biomedical Innovation (CBI). He conducts interdisciplinary research in metabolic engineering focusing on the fundamental physiology, biochemistry and molecular genetics of important organisms.

Professor Sinskey is well known in the biopharmaceutical industry and has been a Scientific Co-founder of several biotechnology companies, including Genzyme Corporation, Natural Pharmaceuticals, Metabolix, Merrimack Pharmaceuticals, and Tepha. Dr. Sinskey has given more than 300 presentations at US and international scientific meetings and congresses. He has received 31 issues patents, has made more than 30 invention disclosures and has published more than 300 scientific papers in leading peer-reviewed journals for biology, metabolic engineering, and biopolymer engineering.

His current research focuses on the genetics and biochemistry of carbon storage in biological systems including biopolymers and triacylglycerides. Investigations include studies with a variety of feedstocks to fuels, chemicals and biopolymers.

Dr. Sinskey received his undergraduate degree from the University of Illinois at Urbana-Champaign and his ScD in Microbiology and Food Science from the Massachusetts Institute of Technology. His post-doctoral work was done at the Harvard School of Public Health.